title: Relation of platelet inactivation with intravenous glycoprotein IIb/IIIa antagonists to major bleeding (from the GOLD study).
authors.affiliation: Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA., USA
authors.forename: Michael R
authors.initials: MR
authors.lastname: Tamberella
authors.forename: Deepak L
authors.initials: DL
authors.lastname: Bhatt
authors.forename: Derek P
authors.initials: DP
authors.lastname: Chew
authors.forename: Dean J
authors.initials: DJ
authors.lastname: Kereiakes
authors.forename: Eric J
authors.initials: EJ
authors.lastname: Topol
authors.forename: Steven R
authors.initials: SR
authors.lastname: Steinhubl
mesh_terms: D015906:Angioplasty, Balloon, Coronary; D001792:Blood Platelets / Q000187:drug effects / Q000502:physiology; D005260:Female; D006331:Heart Diseases / Q000517:prevention & control*; D006470:Hemorrhage / Q000209:etiology* / Q000517:prevention & control*; D006801:Humans; D008297:Male; D010974:Platelet Aggregation / Q000187:drug effects; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*; D011446:Prospective Studies
chemical_list: D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex